An RNA-based digital circulating tumor cell signature is predictive of drug response and early dissemination in prostate cancer

Blood-based biomarkers are critical in metastatic prostate cancer, where characteristic bone metastases are not readily sampled, and they may enable risk stratification in localized disease. We established a sensitive and high-throughput strategy for analyzing prostate circulating tumor cells (CTCs)...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Discov
Main Authors: Miyamoto, David T., Lee, Richard J., Kalinich, Mark, LiCausi, Joseph, Zheng, Yu, Chen, Tianqi, Milner, John D., Emmons, Erin, Ho, Uyen, Broderick, Katherine, Silva, Erin, Javaid, Sarah, Kwan, Tanya Todorova, Hong, Xin, Dahl, Douglas M., McGovern, Francis J., Efstathiou, Jason A., Smith, Matthew R., Sequist, Lecia V., Kapur, Ravi, Wu, Chin-Lee, Stott, Shannon L., Ting, David T., Giobbie-Hurder, Anita, Toner, Mehmet, Maheswaran, Shyamala, Haber, Daniel A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6342192/
https://ncbi.nlm.nih.gov/pubmed/29301747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-16-1406
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים